No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
AMRX Amneal Pharmaceuticals
- 7.780
- +0.030+0.39%
Close Dec 20 16:00 ET
- 7.780
- 0.0000.00%
Post 20:01 ET
2.41BMarket Cap-9.15P/E (TTM)
7.860High7.570Low1.66MVolume7.690Open7.750Pre Close12.88MTurnover1.15%Turnover RatioLossP/E (Static)309.84MShares9.47552wk High-25.76P/B1.13BFloat Cap5.01052wk Low--Dividend TTM144.71MShs Float24.480Historical High--Div YieldTTM3.74%Amplitude1.240Historical Low7.766Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Piper Sandler Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $11
Amneal to Participate at Upcoming Investor Conferences
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Sector Update: Health Care Stocks Advance Premarket Friday
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
Express News | Amneal Pharmaceuticals Inc - FDA Review of Dhe Autoinjector Nda Expected by Q2 2025
Heat List
US
Overall
Symbol
Price
% Chg
No Data